Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States.

MLA

Woloshin, Steven, et al. “Estimating the Impact of Adding C-Reactive Protein as a Criterion for Lipid Lowering Treatment in the United States.” Journal of General Internal Medicine, vol. 22, no. 2, Feb. 2007, pp. 197–204. EBSCOhost, https://doi.org/10.1007/s11606-006-0033-z.

APA

Woloshin, S., Schwartz, L. M., Kerin, K., & Welch, H. G. (2007). Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States. Journal of General Internal Medicine, 22(2), 197–204. https://doi.org/10.1007/s11606-006-0033-z

Chicago

Woloshin, Steven, Lisa M Schwartz, Kevin Kerin, and H Gilbert Welch. 2007. “Estimating the Impact of Adding C-Reactive Protein as a Criterion for Lipid Lowering Treatment in the United States.” Journal of General Internal Medicine 22 (2): 197–204. doi:10.1007/s11606-006-0033-z.